June 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountinovio.com
Global Rank
#1,721,930
268,708Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
47.35%
Pages per Visit
1.63
Avg Visit Duration
00:00:18
- Company
- INOVIO
Top 10 inovio.com Competitors
The Top 10 Sites Like inovio.com in June 2026 are ranked by their affinity to inovio.com in terms of keyword traffic, audience targeting, and market overlap
Global Rank
#1,645,969
7,392Bounce Rate
50.92%
Pages per Visit
1.85
Avg Visit Duration
00:01:22
Similarity Score
100%Purpose The purpose of this Policy is to provide the highest-level principles and expectations of Humacyte, Inc. and its subsidiaries (collectively, the “Company”) regarding the duties and obligations of all Company personnel to avoid situations that present, or create the appearance of, a potential conflict of interest. This Policy aligns with the Company’s Code of … Continued
- Company
- Humacyte
Global Rank
#2,031,932
116,056Bounce Rate
54.73%
Pages per Visit
1.70
Avg Visit Duration
00:00:27
Similarity Score
98%Krystal is committed to improving the lives or patients and families. Learn more about the resources available and access personalized support with Krystal Connect™ by calling 1-844-5-KRYSTAL.
Global Rank
#2,067,185
164,831Bounce Rate
49.97%
Pages per Visit
1.64
Avg Visit Duration
00:00:40
Similarity Score
95%Discover a vast collection of informative resources in our library, including brochures, app notes, scientific posters, webinar, presentations etc. Browse here
- Company
- MaxCyte
Global Rank
#2,191,254
551,055Bounce Rate
42.92%
Pages per Visit
1.64
Avg Visit Duration
00:00:23
Similarity Score
93%Find out how RNA therapy works, how it differs from gene therapy and why we use it to treat genetic diseases that are currently untreatable.
- Company
- ProQR Therapeutics
Global Rank
#2,354,679
399,852Bounce Rate
42.27%
Pages per Visit
1.80
Avg Visit Duration
00:00:21
Similarity Score
92%Do you have a question or comment? Contact Cabaletta Bio today to find out more about our cell therapy product candidates for patients with autoimmune diseases.
- Company
- Cabaletta Bio
Global Rank
#1,377,227
127,289Bounce Rate
36.1%
Pages per Visit
2.42
Avg Visit Duration
00:01:42
Similarity Score
89%Ed Kaye’s decades-long career has always centered around helping children with severe diseases, resulting in seven approved medicines that have helped change the lives...
- Company
- Stoke Therapeutics
Global Rank
#1,748,931
3,227Bounce Rate
49.49%
Pages per Visit
1.94
Avg Visit Duration
00:00:37
Similarity Score
88%computational tools and libraries for crispr/cas9-derived rna-guided engineered nucleases (rgens).
- Company
- - -
- Industry
- - -
Global Rank
#1,946,772
30,992Bounce Rate
41.07%
Pages per Visit
2.63
Avg Visit Duration
00:01:43
Similarity Score
87%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
96.23%
Pages per Visit
1.22
Avg Visit Duration
00:00:16
Similarity Score
84%VoxCell develops physiologically relevant 3D vascularized tissue models that accelerate drug development and personalized medicine.
- Company
- - -
- Industry
- - -
Bounce Rate
17.79%
Pages per Visit
7.66
Avg Visit Duration
00:04:52
Similarity Score
81%inovio.com's top 5 competitors in June 2026 are: aviditybiosciences.com, humacyte.com, krystalbio.com, maxcyte.com, and more.
According to Similarweb data of monthly visits, inovio.com’s top competitor in June 2026 is aviditybiosciences.com. inovio.com 2nd most similar site is humacyte.com, and closing off the top 3 is krystalbio.com.
maxcyte.com ranks as the 4th most similar website to inovio.com and proqr.com ranks fifth in June 2026.
The other five competitors in the top 10 list are cabalettabio.com, stoketherapeutics.com, rgenome.net, stemcell.uci.edu, and voxcell.com.